PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
33.01%
Revenue growth 1.25-1.5x 6247.T's 27.87%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
2.27%
Gross profit growth under 50% of 6247.T's 24.65%. Michael Burry would be concerned about a severe competitive disadvantage.
3437.74%
EBIT growth above 1.5x 6247.T's 273.22%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
-90.62%
Negative operating income growth while 6247.T is at 120.72%. Joel Greenblatt would press for urgent turnaround measures.
1636.83%
Net income growth above 1.5x 6247.T's 255.94%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
1636.88%
EPS growth above 1.5x 6247.T's 255.76%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
1636.88%
Diluted EPS growth above 1.5x 6247.T's 255.76%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.00%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-93.78%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-37.77%
Negative 5Y CAGR while 6247.T stands at 33.11%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-30.47%
Negative 3Y CAGR while 6247.T stands at 22.49%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
115.89%
Below 50% of 6247.T's 1458.64%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
197.59%
5Y net income/share CAGR similar to 6247.T's 216.27%. Walter Schloss might see both on parallel mid-term trajectories.
355.48%
3Y net income/share CAGR 1.25-1.5x 6247.T's 288.32%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
No Data
No Data available this quarter, please select a different quarter.
184.50%
5Y equity/share CAGR above 1.5x 6247.T's 30.47%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
35.65%
3Y equity/share CAGR above 1.5x 6247.T's 7.75%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
76.26%
AR growth of 76.26% while 6247.T is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
159.90%
Inventory growth well above 6247.T's 0.05%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
92.27%
Asset growth above 1.5x 6247.T's 4.65%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
13.38%
BV/share growth above 1.5x 6247.T's 3.46%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
331.15%
Debt growth of 331.15% while 6247.T is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
-100.00%
Our R&D shrinks while 6247.T invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
99.74%
We expand SG&A while 6247.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.